Related references
Note: Only part of the references are listed.Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
S. Wang et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma
Mark S. Shiroishi et al.
NEURO-ONCOLOGY (2016)
Assessment of Brain Tumor Response: RANO and Its Offspring
Sylvia C. Eisele et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Yan Michael Li et al.
JOURNAL OF NEUROSURGERY (2016)
Imaging Surrogates of Infiltration Obtained Via Multiparametric Imaging Pattern Analysis Predict Subsequent Location of Recurrence of Glioblastoma
Hamed Akbari et al.
NEUROSURGERY (2016)
Diffusion and Perfusion MRI to Differentiate Treatment-Related Changes Including Pseudoprogression from Recurrent Tumors in High-Grade Gliomas with Histopathologic Evidence
A. J. Prager et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis
Jean-Michel Lemee et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Gradient of Apparent Diffusion Coefficient Values in Peritumoral Edema Helps in Differentiation of Glioblastoma From Solitary Metastatic Lesions
Pierre Lemercier et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2014)
Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: A systematic review and meta-analysis
Hui Zhang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
Matthew M. Grabowski et al.
JOURNAL OF NEUROSURGERY (2014)
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
Kaisorn L. Chaichana et al.
NEURO-ONCOLOGY (2014)
The epidemiology of glioma in adults: a state of the science review
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Pattern Analysis of Dynamic Susceptibility Contrast-enhanced MR Imaging Demonstrates Peritumoral Tissue Heterogeneity
Hamed Akbari et al.
RADIOLOGY (2014)
Outcome Prediction in Patients with Glioblastoma by Using Imaging, Clinical, and Genomic Biomarkers: Focus on the Nonenhancing Component of the Tumor
Rajan Jain et al.
RADIOLOGY (2014)
MRI perfusion in determining pseudoprogression in patients with glioblastoma
Robert J. Young et al.
CLINICAL IMAGING (2013)
Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
Elke Hattingen et al.
NEURO-ONCOLOGY (2013)
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab
Benjamin M. Ellingson et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging
Ramon F. Barajas et al.
NEURO-ONCOLOGY (2012)
Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma
L. C. Hygino da Cruz et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Signal intensity in T2' magnetic resonance imaging is related to brain glioma grade
Laura Saitta et al.
EUROPEAN RADIOLOGY (2011)
Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas
Stella Blasel et al.
ACTA NEUROCHIRURGICA (2010)
Rapid magnetic resonance quantification on the brain: Optimization for clinical usage
J. B. M. Warnties et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Diffuse glioma growth: a guerilla war
An Claes et al.
ACTA NEUROPATHOLOGICA (2007)